scholarly article | Q13442814 |
P2093 | author name string | G Schreiber | |
J Piehler | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
P304 | page(s) | 57-67 | |
P577 | publication date | 1999-05-01 | |
P1433 | published in | Journal of Molecular Biology | Q925779 |
P1476 | title | Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNalpha2. | |
P478 | volume | 289 |
Q41304070 | A Biosensor Study Indicating That Entropy, Electrostatics, and Receptor Glycosylation Drive the Binding Interaction between Interleukin-7 and Its Receptor |
Q30882993 | A peptide mimetic of human interferon (IFN)-beta |
Q33274608 | An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities |
Q44684462 | An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA. |
Q33251738 | Antagonist peptides of human interferon-alpha2b isolated from phage display library inhibit interferon induced antiviral activity |
Q35932292 | Antiviral activities of the soluble extracellular domains of type I interferon receptors |
Q36344846 | Binding of interferon reduces the force of unfolding for interferon receptor 1. |
Q33434897 | Characterization of the bovine type I IFN locus: rearrangements, expansions, and novel subfamilies |
Q34524706 | Determination of the two-dimensional interaction rate constants of a cytokine receptor complex |
Q64241515 | Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects |
Q38923245 | Enhancement of cell type specificity by quantitative modulation of a chimeric ligand |
Q33893739 | Fundamental aspects of protein-protein association kinetics |
Q33804260 | High yield soluble bacterial expression and streamlined purification of recombinant human interferon α-2a. |
Q33330222 | Identification of antiviral mimetic peptides with interferon alpha-2b-like activity from a random peptide library using a novel functional biopanning method |
Q34077504 | Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions |
Q38315801 | Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta |
Q27661869 | Intermolecular Interactions in a 44 kDa Interferon−Receptor Complex Detected by Asymmetric Reverse-Protonation and Two-Dimensional NOESY |
Q37319877 | Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers |
Q34525874 | Kinetic studies of protein-protein interactions |
Q42183167 | Kinetics of ligand-receptor interaction reveals an induced-fit mode of binding in a cyclic nucleotide-activated protein |
Q30499953 | Lateral ligand-receptor interactions on membranes probed by simultaneous fluorescence-interference detection |
Q37164886 | Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity |
Q30597262 | Live cell micropatterning reveals the dynamics of signaling complexes at the plasma membrane |
Q35031568 | Multifaceted activities of type I interferon are revealed by a receptor antagonist |
Q36057129 | Mutations of the human interferon alpha-2b (hIFNα-2b) gene in cancer patients receiving radiotherapy. |
Q38402828 | Mutations of the human interferon alpha-2b gene in brain tumor patients exposed to different environmental conditions |
Q40855474 | New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface |
Q27671547 | Observation of Intermolecular Interactions in Large Protein Complexes by 2D-Double Difference Nuclear Overhauser Enhancement Spectroscopy: Application to the 44 kDa Interferon–Receptor Complex |
Q40590419 | Optimizing the binding affinity of a carrier protein: a case study on the interaction between soluble ifnar2 and interferon beta. |
Q37788252 | PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis |
Q36007339 | Pegylating IFNs at his-34 improves the in vitro antiviral activity through the JAK/STAT pathway |
Q35740830 | Production and characterization of thirteen human type-I interferon-α subtypes |
Q34656190 | Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2. |
Q30830679 | Receptor dimer stabilization by hierarchical plasma membrane microcompartments regulates cytokine signaling. |
Q27310374 | Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling |
Q34208310 | Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. |
Q35032786 | Role of benzyl alcohol in the unfolding and aggregation of interferon α-2a. |
Q90547626 | Self-assembly of robust gold nanoparticle monolayer architectures for quantitative protein interaction analysis by LSPR spectroscopy |
Q40481236 | Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway. |
Q35139921 | Stochastic receptor expression determines cell fate upon interferon treatment |
Q27687338 | Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation |
Q45336530 | Structural characterization of oligosaccharides in recombinant soluble human interferon receptor 2 using fluorophore-assisted carbohydrate electrophoresis |
Q33949253 | Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking |
Q73291118 | Survey of the 1999 surface plasmon resonance biosensor literature |
Q41765858 | The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling |
Q27641616 | The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding |
Q54399469 | The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities. |
Q36943194 | Two interferons alpha influence each other during their interaction with the extracellular domain of human type interferon receptor subunit 2 |
Search more.